Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Mitsubishi to copromote OrthoLogic 1000 in Japan

Nov. 1, 1996

FCP-3P1 in Canadian clinical trials

Nov. 1, 1996

Canadian researchers claim hPTH analogues for osteoporosis

Nov. 1, 1996

Lilly continues to investigate new agents for women's health

Nov. 1, 1996

Theratechnologies-Beaufour Ipsen agreement on TH-9506

Oct. 25, 1996

Bristol-Myers Squibb describes potent and selective beta3-adrenoceptor agonist

Oct. 25, 1996

Lilly claims compounds for menopausal disorders

Oct. 25, 1996

Antiobesity proteins described by Lilly

Oct. 25, 1996

First and only Estrophasic oral contraceptive approved

Oct. 18, 1996

Menorest approved in Belgium

Oct. 18, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 27, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...
In the clinic for May 26, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: 858, A2 Biotherapeutics, AC Immune, Agendia, Agenus, Aktis, Ascentage,...